Initial Progression-Free Survival after Non-First Line TKIs Therapy Potentially Guides Immediate Treatment after Its Failure in Advanced Non-Small Cell Lung Cancer

por Wang, Fang, Guo, Gui-fang, Qiu, Hui-juan, He, Wen-zhuo, Zhou, Fei-fei, Chen, Xu-xian, Hu, Pi-li, Zhang, Bei, Yin, Chen-xi, Zhang, Li, Xia, Liang-ping
Publicado 2012

The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial

por Tang, Lin-Quan, Li, Xiao-Yun, Li, Zhi-Ming, Liu, Zhi-Gang, Lin, Miao-Zhen, Zhou, Huan, Yu, Qi-Wen, Zhou, Jian, Zhao, Chong, Chen, Ze-Bin, Wang, Xi-Cheng, Peng, Jia-Yu, Chen, Qiu-Yan, Fang, Wen-Feng, Yang, Yun-Peng, Zhang, Bei, Xia, Liang-Ping, Hu, Pi-Li, Hu, Wei-Han, Li, Yi-Jie, Mai, Hai-Qiang, Cai, Xiu-Yu
Publicado 2023